Industry Trend Analysis - US To Remain The Most Attractive Pharmaceutical Market Globally - OCT 2017
BMI View: With a score of 87.6 out of 100, the US pharmaceutical market ranks first both regionally and globally within BMI's Innovative Pharmaceutical Risk/Reward Index, a reflection of its unquestionable attractiveness and limited risks relative to other markets. Over several years, t he US has ranked first consistently thanks to strong scores across the four major sub-categories. We expect this to remain the case for the foreseeable future, with no other markets expected to top the vast commercial potential of the country's pharmaceutical market.
US: Innovative Pharmaceuticals RRI - Global And Regional Ranks
Regional rank (out of 19): 1 st
US: Innovative Pharmaceuticals Risk/Reward Index Q417 Note: Scores out of 100; higher scores = lower risk. Source: BMI's Innovative Risk/Reward Index
This article is part of our Americas coverage. To access this article subscribe now or sign up for free trial